Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze(TM … – MarketWatch (press release)

Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze(TM
MarketWatch (press release)
Currently available adenosine agonists must be used with caution or are contraindicated in patients with asthma and COPD. The findings, presented at the
Clinical Data Reveals Positive Results From Early-stage Trials Of Stedivaze Stock Markets Review

all 13 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *